News

Obtained in a collaborative project with the US-based Paragon Bioservices, the data showed that CAP cells were able to produce very high titers of RSV. When compared to

The DSMC met to review available patient data as part of the planned interim analysis, scheduled to occur following 222 patient events. The DSMC, following its review, recommended

C3 Jian’s C16G2 is a synthetic peptide derived from the company’s pheromone signaling platform technology referred to as STAMPs (specifically targeted antimicrobial peptides). The drug targets the specific

Genentech is currently marketing Xeloda in the US. Teva claims that it was the first to receive approval on its abbreviated new drug application from the US Food

The research group of Dr Francesco Saverio Tedesco from the UCL department of Cell and Developmental Biology is conducting the research, which is being supported through funding of

Curcumin is an active product that is generated from the spice, turmeric. It has been consumed for centuries in other parts of the world without posing any side

The FDA’s Fast Track process is designed to facilitate the development and expedite the review of drugs to treat serious conditions that fill an unmet medical need, with

The patent includes claims to the use of the company’s drug candidate, Trimesta (oral estriol), in conjunction with a gestagen for the treatment of multiple sclerosis (MS) and

The DSMB’s review of the efficacy data is still pending. Northwest Biotherapeutics chief technical officer Dr. Marnix Bosch noted the company is pleased with the recommendation of the